PXL: a nucleic acid-binding module of the promyelocytic leukemia protein.
- 1Department of Molecular Biology and Biophysics, School of Medicine, University of Connecticut, 263 Farmington Avenue, Farmington, CT 06030, United States.
Abstract
The promyelocytic leukemia protein (PML) is a stress-response factor that assembles into PML nuclear bodies, dynamic subnuclear compartments involved in tumor suppression and antiviral defense. The most abundant isoform, PML-1, has been linked to transcriptional regulation, genome stability, and antiviral responses, yet the molecular basis of these functions remains unclear and is generally attributed to proteins associated with PML nuclear bodies. Here, we report that PML-1 itself harbors a previously structurally uncharacterized nucleic acid-binding domain. The domain, termed PXL, is encoded by exon 9 of the PML gene and is unique to isoform 1. Its structure reveals an exonuclease III fold, but lacks the catalytic residues required for activity, defining PXL as a pseudo-exonuclease. Biochemical, structural, mutational, and cellular analyses demonstrate that PXL specifically binds G-rich oligonucleotides implicated in G-quadruplex formation and displays a strong in vitro preference for polyUG RNA. Furthermore, deletion of the PXL domain significantly decreases PML colocalization with G-quadruplexes in cells, downregulates genomic maintenance pathways, and modulates the expression of E2F target and interferon-α response genes. These findings provide a molecular basis for previous observations implicating PML in nucleic acid-associated functions and establish a mechanistic framework for future studies of PML-mediated stress responses, nuclear organization, and gene regulation.
Related
- Extramedullary Relapse of Acute Promyelocytic Leukemia in the Middle Ear after All-Trans Retinoic Acid Combined with Chemotherapy
- Severe Multiorgan Failure Associated with Differentiation Syndrome in a High-risk Acute Promyelocytic Leukemia Patient with Concurrent Influenza A
- Acute Promyelocytic Leukemia with t(11;17)(q23.2;q21.2) Treated with Haploidentical Transplantation Using Post-transplant Cyclophosphamide
- Secondary Intracranial Hypertension During ATRA/ATO Therapy in High-Risk Acute Promyelocytic Leukemia: A Case Report and Practical Management Framework.
- VAEBAC: a representation-learning framework for proteome-scale prediction of amyloidogenic proteins and functional stratification of nucleic-acid-binding proteins.
BibTeX
@article{fairchild2026nucleic,
title = {{PXL: a nucleic acid-binding module of the promyelocytic leukemia protein.}},
author = {Daniel Fairchild and Irina V Semenova and Dane Geddes-Buehre and Yunfeng Li and Renata Szczepaniak and Sandra K Weller and Bing Hao and Irina Bezsonova},
journal = {Nucleic acids research},
year = {2026},
month = oct,
doi = {10.1093/nar/gkag966},
url = {https://europepmc.org/article/MED/42866950},
note = {CC BY},
}
RIS
TY - JOUR
TI - PXL: a nucleic acid-binding module of the promyelocytic leukemia protein.
AU - Daniel Fairchild
AU - Irina V Semenova
AU - Dane Geddes-Buehre
AU - Yunfeng Li
AU - Renata Szczepaniak
AU - Sandra K Weller
AU - Bing Hao
AU - Irina Bezsonova
PY - 2026
DA - 2026/10/01
JO - Nucleic acids research
DO - 10.1093/nar/gkag966
UR - https://europepmc.org/article/MED/42866950
AB - The promyelocytic leukemia protein (PML) is a stress-response factor that assembles into PML nuclear bodies, dynamic subnuclear compartments involved in tumor suppression and antiviral defense. The most abundant isoform, PML-1, has been linked to transcriptional regulation, genome stability, and antiviral responses, yet the molecular basis of these functions remains unclear and is generally attributed to proteins associated with PML nuclear bodies. Here, we report that PML-1 itself harbors a previously structurally uncharacterized nucleic acid-binding domain. The domain, termed PXL, is encoded by exon 9 of the PML gene and is unique to isoform 1. Its structure reveals an exonuclease III fold, but lacks the catalytic residues required for activity, defining PXL as a pseudo-exonuclease. Biochemical, structural, mutational, and cellular analyses demonstrate that PXL specifically binds G-rich oligonucleotides implicated in G-quadruplex formation and displays a strong in vitro preference for polyUG RNA. Furthermore, deletion of the PXL domain significantly decreases PML colocalization with G-quadruplexes in cells, downregulates genomic maintenance pathways, and modulates the expression of E2F target and interferon-α response genes. These findings provide a molecular basis for previous observations implicating PML in nucleic acid-associated functions and establish a mechanistic framework for future studies of PML-mediated stress responses, nuclear organization, and gene regulation.
SN - 0305-1048
SN - 1362-4962
ER -